NCT01936415

Brief Summary

In a prospective randomised study two uncemented tibial components with different coating (Vanguard® porous coating, Biomet and Regenerex® Primary Tibial Tray, Trabecular Metal coating, Biomet) used for total knee arthroplasty (TKA) are evaluated. Both tibial component coatings are designed to provide excellent conditions for bone ingrowth. The differences between the two tibial components are evaluated by measurements of migration of the tibial component assessed by Radiostereometric analysis (RSA) and measurements of the adaptive bone remodeling of the proximal tibial assessed by dual energy X-ray absorptiometry (DEXA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2010

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2012

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 6, 2013

Completed
Last Updated

September 6, 2013

Status Verified

September 1, 2013

Enrollment Period

3.3 years

First QC Date

April 30, 2012

Last Update Submit

September 3, 2013

Conditions

Keywords

Knee prosthesis

Outcome Measures

Primary Outcomes (1)

  • Migration of the tibial component

    The differences between the two tibial components are evaluated by measurements of migration of the tibial component assessed by Radiostereometric analysis (RSA) and measurements of the adaptive bone remodeling of the proximal tibial assessed by dual energy X-ray absorptiometry (DEXA). The differens is messured in millimeters.

    three years

Study Arms (2)

Regenerex

EXPERIMENTAL

One of the two prosthesis investegated

Device: Regenerex

Vanguard

ACTIVE COMPARATOR
Device: Vanguard

Interventions

VanguardDEVICE

A prospective randomized study where the patients are randomized to receive one of two prostheses (tibial components) with different coating: Vanguard pourous coating, Biomet and Regenerex® Primary Tibial Tray, Biomet. Both prostheses are available and approved by the FDA. The main difference between the implants is the coating of the tibial tray

Vanguard
RegenerexDEVICE
Regenerex

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe osteoarthrosis of the knee with indication for a TKA.
  • Age between 18 and 70 years.

You may not qualify if:

  • Diseases affecting the bone metabolism (osteoporosis, Pagets disease, hyperparathyreoidism etc.).
  • Patients estimated not to be able to understand the "Information to patients" papers or do not want to participate in the study.
  • Premenopausal women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

1. Knee Unit Hørsholm, Department of Orthopaedic Surgery, Hillerød Hospital, Denmark

Hillerød, 3400, Denmark

Location

Related Publications (1)

  • Winther NS, Jensen CL, Jensen CM, Lind T, Schroder HM, Flivik G, Petersen MM. Comparison of a novel porous titanium construct (Regenerex(R)) to a well proven porous coated tibial surface in cementless total knee arthroplasty - A prospective randomized RSA study with two-year follow-up. Knee. 2016 Dec;23(6):1002-1011. doi: 10.1016/j.knee.2016.09.010. Epub 2016 Oct 19.

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pricipal Incestigatior. MD, Consultant in Orthopeadic.

Study Record Dates

First Submitted

April 30, 2012

First Posted

September 6, 2013

Study Start

May 1, 2010

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

September 6, 2013

Record last verified: 2013-09

Locations